Delivery Order SPE2DB24D3015-SPE2DB25FGBAY
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,267.45 to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 mL pen (0.5 mL), a diabetes medication. The contract is firm fixed price with no set-aside designation and carries an ultimate completion date of April 28, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,897.78 to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 ml pens (a diabetes medication) on September 3, 2025, with a completion date of September 4, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's Corporate Office location in Conshohocken, Pennsylvania. The contract represents a relatively small transaction within...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,641.17 for Mounjaro 7.5 mg/0.5 mL pens on August 12, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a single shipment of this diabetes medication to support federal medical...
- The Defense Logistics Agency awarded a $2,853.81 delivery order to AmerisourceBergen Drug Corp on July 17, 2025, for the supply of Mounjaro 5 mg/0.5 mL pens (0.5 mL units), a diabetes medication. The contract utilizes firm fixed pricing and is classified as a non-set-aside award, indicating it was competitively procured. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and is a major pharmaceutical distributor providing critical medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $32,899.65 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pens on August 25, 2025, with completion targeted for August 26, 2025. This firm fixed-price, competitively awarded delivery order carries no set-aside designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract procures a diabetes medication used across military and federal healthcare systems...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,635.27 for Mounjaro 5 mg/0.5 mL pen (0.5 mL), a diabetes medication, with an ultimate completion date of July 15, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $22,722.65 firm fixed price delivery order for Mounjaro 5 mg/0.5 mL pens on June 30, 2025, with completion scheduled for July 1, 2025. This non-set-aside contract represents a single delivery of the diabetes medication to support federal healthcare needs. The award was made to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,360.45 to AmerisourceBergen Drug Corp for the supply of Mounjaro 2.5 mg/0.5 mL pen (0.5 mL), a diabetes medication. The contract, awarded on May 6, 2025, with an ultimate completion date of May 7, 2025, was competitively awarded without a set-aside designation under firm fixed-price terms. Performance will take place at the company's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,176.72 for Mounjaro 10 mg/0.5 ml pen (0.5ml) on July 29, 2025, with an ultimate completion date of July 30, 2025. This firm fixed price, non-set-aside contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction for this diabetes medication under a larger contract vehicle. This award is a child delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,249.48 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 ml pen (0.5ml), a diabetes medication. The contract, awarded on August 26, 2025, with an ultimate completion date of August 27, 2025, was competitively awarded with no set-aside designation and employs firm fixed-price pricing. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- SPE2DB24D3015Indefinite Delivery Contract
- SPE2DB24D3015-SPE2DB25FGBAYDelivery Order
The Defense Logistics Agency awarded a $6,670.47 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 0.5 milliliter pens of Mounjaro 2.5 milligrams, a diabetes medication. The contract was competitively awarded with no set-aside designation and is scheduled for completion by September 22, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of medications and medical supplies to support military healthcare programs worldwide. The DLA's Medical Supply Chain utilizes this prime contract vehicle to procure essential pharmaceutical commodities across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.7k | 9/19/25 |